Mechanically, to explore whether solamargine regulates the Erk pathway by targeting a specific mRNA, we selected genes reported in recent years to regulate the Erk pathway in cervical cancer, including PBK, RACK1, CXCL3, TRIP4, and SEMA3C, for study [25–29]. This evidence concerns the gene CXCL3 and cervical cancer.